High levels of free testosterone in women tied to 44 percent reduced risk of asthma, finds study
High levels of free testosterone in women tied to 44 per cent reduced risk of asthma, revealed a study published in the American Journal of Respiratory and Critical Care Medicine. This was the first population-based study which assessed the association of sex hormones with asthma risks in males and females.
The study also showed that women with asthma appear more likely to have lower levels of "free" (not attached to proteins) testosterone than women who do not have asthma.
Read also: Testosterone-boosting supplements not effective, according to new research
In "Sex Steroid Hormones and Asthma in a Nationwide Study of U.S. Adults," Yueh-Ying Han, PhD; Erick Forno, MD, MPH; and Juan C. Celedón, MD, DrPH; also report that among obese women, those with asthma are more likely to have lower levels of estradiol, another sex hormone, than those who do not have asthma. In addition, the researchers found that among non-obese men, those with asthma are more likely to have lower levels of estradiol than those who do not have asthma.
Previous studies have reported specific differences between pediatric and adult asthma patients based on sex. Although asthma is more common in boys than in girls, asthma is more common in women than in men.
Given that sex hormones may explain these sex-specific differences, lead author Dr. Han, an epidemiologist at the UPMC Children's Hospital of Pittsburgh, and senior author Dr. Celedón, the Niels K. Jerne Professor of Pediatrics and Medicine at the University of Pittsburgh and chief of pulmonary medicine at UPMC Children's Hospital of Pittsburgh, said they conducted this study to examine whether sex hormones are associated with asthma in adult men and women. They also wanted to test whether any association varies between obese and non-obese individuals.
Read also: 3-in-1 inhaler may improve treatment adherence and reduce asthma attacks: The Lancet
The authors analyzed information from 9,238 adults, ages 18-79, who participated in the U.S. National Health and Nutrition Examination Survey (NHANES) from 2013-16. Overall, 9 percent of the participants had asthma. Among women, the asthma rate was double that of men: 12.5 percent vs. 6.1 percent.
The study found that elevated levels of sex hormones reduced the likelihood of asthma. Specifically:
- In women, levels of free testosterone in the highest quartile compared to the lowest quartile were associated with 44 percent lower odds of asthma.
- Among obese women, levels of free testosterone in the highest quartile compared to the lowest quartile were associated with 41 percent lower odds of asthma.
- Among obese women, levels of estradiol in the highest quartile compared to the lowest quartile were associated with 57 percent lower odds of asthma. Levels of estradiol in the second and third quartiles compared to the lowest quartile were also associated with reduced odds of asthma in these women.
- Among non-obese men, levels of estradiol in the highest quartile compared to the lowest quartile were associated with 56 percent lower odds of asthma.
Because the study was cross-sectional, it cannot determine whether sex hormone levels led to asthma. Study limitations also include lack of information about the current menopausal status of participating women, insulin resistance, or environmental exposure to chemicals that may have affected sex hormone levels.
Read also: FDA approves first targeted biologic mepolizumab for severe Pediatric Eosinophilic Asthma
"Our study results suggest that the circulating sex hormones estradiol and free testosterone contribute to sex differences in asthma among adults," Dr. Celedón said. "Furthermore, obesity appears to modify the effect of such hormones on asthma in women and men."
He added that longitudinal studies are needed to confirm and expand on these findings.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd